$RIGL
RIGEL PHARMACEUTICALS INC

2022 Q3 Form 10-Q Financial Statement

#000155837022011638 Filed on August 02, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $22.41M $29.82M $16.74M
YoY Change 4.02% 13.53% -79.34%
Cost Of Revenue $250.0K $1.036M $121.0K
YoY Change 65.56% 703.1% -61.71%
Gross Profit $22.16M $28.78M $16.61M
YoY Change 3.59% 10.12% -79.41%
Gross Profit Margin 98.88% 96.53% 99.28%
Selling, General & Admin $25.90M $26.98M $27.40M
YoY Change 13.2% 20.57% 23.87%
% of Gross Profit 116.86% 93.74% 164.93%
Research & Development $14.67M $14.77M $15.47M
YoY Change -19.86% -12.14% -8.04%
% of Gross Profit 66.18% 51.3% 93.14%
Depreciation & Amortization $240.0K $237.0K $237.0K
YoY Change -8.05% -7.78% -0.84%
% of Gross Profit 1.08% 0.82% 1.43%
Operating Expenses $40.56M $41.75M $42.88M
YoY Change -1.49% 6.54% 10.09%
Operating Profit -$18.40M -$12.97M -$26.26M
YoY Change -6.99% -0.64% -162.89%
Interest Expense $826.0K $569.0K $1.205M
YoY Change -37.28% -67.65% 148.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$19.04M -$13.49M -$27.45M
YoY Change -9.73% -8.78% -166.5%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$19.04M -$13.49M -$27.45M
YoY Change -9.14% -2.38% -169.48%
Net Earnings / Revenue -84.95% -45.25% -164.0%
Basic Earnings Per Share -$0.11 -$0.08 -$0.16
Diluted Earnings Per Share -$0.11 -$0.08 -$0.16
COMMON SHARES
Basic Shares Outstanding 172.8M 172.1M 171.8M
Diluted Shares Outstanding 172.8M 172.1M 171.8M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $81.64M $89.17M $107.5M
YoY Change -42.97% -41.87% 173.59%
Cash & Equivalents $29.87M $27.20M $24.68M
Short-Term Investments $51.78M $61.97M $82.84M
Other Short-Term Assets $6.157M $7.939M $9.415M
YoY Change 3.79% 20.18% 13.43%
Inventory $7.116M $6.218M $6.764M
Prepaid Expenses
Receivables $15.53M $17.20M $15.24M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $110.4M $120.5M $138.9M
YoY Change -35.45% -34.57% -29.39%
LONG-TERM ASSETS
Property, Plant & Equipment $1.694M $1.832M $2.140M
YoY Change -36.2% -31.26% -14.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $484.0K $403.0K $464.0K
YoY Change -48.24% -52.02% -43.28%
Total Long-Term Assets $5.169M $7.480M $10.14M
YoY Change -66.47% -57.01% -47.3%
TOTAL ASSETS
Total Short-Term Assets $110.4M $120.5M $138.9M
Total Long-Term Assets $5.169M $7.480M $10.14M
Total Assets $115.6M $128.0M $149.1M
YoY Change -38.02% -36.51% -30.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.721M $2.155M $4.614M
YoY Change -13.45% 27.59% -9.44%
Accrued Expenses $37.26M $39.43M $40.92M
YoY Change -11.27% 10.13% 27.88%
Deferred Revenue $1.369M $1.543M $2.097M
YoY Change -56.64% -73.46% -77.93%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $47.27M $54.96M $59.23M
YoY Change -20.27% -7.71% 13.85%
LONG-TERM LIABILITIES
Long-Term Debt $39.47M $29.84M $29.85M
YoY Change 98.46% 50.23% 50.74%
Other Long-Term Liabilities $48.71M $46.89M $53.20M
YoY Change -10.4% -2.78% -7.52%
Total Long-Term Liabilities $48.71M $46.89M $53.20M
YoY Change -10.4% -2.78% -7.52%
TOTAL LIABILITIES
Total Short-Term Liabilities $47.27M $54.96M $59.23M
Total Long-Term Liabilities $48.71M $46.89M $53.20M
Total Liabilities $95.98M $101.8M $112.4M
YoY Change -15.55% -5.5% 2.62%
SHAREHOLDERS EQUITY
Retained Earnings -$1.384B -$1.365B -$1.351B
YoY Change 6.35% 6.6% 6.7%
Common Stock $1.364B $1.362B $1.359B
YoY Change 0.99% 0.98% 1.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$19.83M -$3.677M $6.798M
YoY Change
Total Liabilities & Shareholders Equity $115.6M $128.0M $149.1M
YoY Change -38.02% -36.51% -30.98%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$19.04M -$13.49M -$27.45M
YoY Change -9.14% -2.38% -169.48%
Depreciation, Depletion And Amortization $240.0K $237.0K $237.0K
YoY Change -8.05% -7.78% -0.84%
Cash From Operating Activities -$13.30M -$12.91M -$25.64M
YoY Change 29.17% -123.38% 28.47%
INVESTING ACTIVITIES
Capital Expenditures -$189.0K $36.00K $224.0K
YoY Change 11.18% -108.82% 215.49%
Acquisitions
YoY Change
Other Investing Activities $10.64M $21.06M $22.85M
YoY Change -124.07% -142.76% 200.7%
Cash From Investing Activities $10.46M $21.09M $22.63M
YoY Change -123.55% -142.48% 200.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.511M -5.662M 8.797M
YoY Change 1911.31% -109.56% 319.5%
NET CHANGE
Cash From Operating Activities -13.30M -12.91M -25.64M
Cash From Investing Activities 10.46M 21.09M 22.63M
Cash From Financing Activities 5.511M -5.662M 8.797M
Net Change In Cash 2.665M 2.522M 5.789M
YoY Change -104.9% -96.11% -156.06%
FREE CASH FLOW
Cash From Operating Activities -$13.30M -$12.91M -$25.64M
Capital Expenditures -$189.0K $36.00K $224.0K
Free Cash Flow -$13.11M -$12.95M -$25.86M
YoY Change 29.48% -123.27% 29.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Costs And Expenses
CostsAndExpenses
78577000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171961000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169997000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
129000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-336000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1157000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
445000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5245000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9703000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
11000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
403000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
974000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25690000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2596000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38548000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001034842
us-gaap Investment Income Interest
InvestmentIncomeInterest
17000
CY2022Q2 us-gaap Interest Expense
InterestExpense
569000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2021Q2 us-gaap Interest Expense
InterestExpense
1759000
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 us-gaap Assets
Assets
128001000
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-29889
us-gaap Interest Expense
InterestExpense
1774000
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
us-gaap Interest Expense
InterestExpense
2244000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
35261000
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3248524
dei Entity Address Address Line1
EntityAddressAddressLine1
1180 Veterans Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
54450000
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
650
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
264000
dei Local Phone Number
LocalPhoneNumber
624-1100
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5915000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12965000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-13048000
us-gaap Operating Income Loss
OperatingIncomeLoss
-39226000
CY2022Q2 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
CY2021Q2 rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
us-gaap Operating Income Loss
OperatingIncomeLoss
28707000
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
42000
rigl Net Sublease Income Expense
NetSubleaseIncomeExpense
dei Entity Registrant Name
EntityRegistrantName
RIGEL PHARMACEUTICALS INC
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
16000
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
RIGL
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
172836336
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27201000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18890000
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
61965000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
106077000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17198000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15472000
CY2022Q2 us-gaap Inventory Net
InventoryNet
6218000
CY2021Q4 us-gaap Inventory Net
InventoryNet
6616000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7939000
us-gaap Investment Income Interest
InvestmentIncomeInterest
63000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
71450000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172147000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170192000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171961000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
50645000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175912000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13492000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13821000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40937000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
29801000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25679000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-22000
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
8000
CY2022Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
14767000
CY2021Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
16807000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
30241000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13821000
us-gaap Net Income Loss
NetIncomeLoss
-40937000
us-gaap Net Income Loss
NetIncomeLoss
25679000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2021Q4 us-gaap Assets
Assets
167328000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
2155000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3795000
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
7525000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10690000
CY2022Q2 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
9213000
CY2021Q4 rigl Accrued Research And Development Liability Current
AccruedResearchAndDevelopmentLiabilityCurrent
10384000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16885000
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12691000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5811000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
167328000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
78298000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7412000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
33633000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13821000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
120521000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
154467000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29819000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26266000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1832000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2184000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46554000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44499000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
42784000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107284000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1036000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9892000
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1543000
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
39314000
us-gaap Costs And Expenses
CostsAndExpenses
85780000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13492000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14791000
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11823000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
13506000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
54955000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
63554000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
759000
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
29835000
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
19914000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46888000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
52727000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
173000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
172000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1361411000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1354190000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-438000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-102000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1364823000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1323886000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3677000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
30374000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
128001000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
26981000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22378000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
54382000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
30374000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27445000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40937000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26480000
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-314000
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
940000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-970000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
2795000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172147000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170192000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
801000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13813000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41273000
CY2021Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
8000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13492000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13514000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3243000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
6798000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13492000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-22000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
599000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2440000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3677000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
34026000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39500000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3000
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2097000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2672000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
142000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1319000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6997000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2306000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
68110000
us-gaap Profit Loss
ProfitLoss
-40937000
us-gaap Profit Loss
ProfitLoss
25679000
us-gaap Share Based Compensation
ShareBasedCompensation
5598000
us-gaap Share Based Compensation
ShareBasedCompensation
4945000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
253000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
474000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
497000
rigl Noncash Interest Expense
NoncashInterestExpense
682000
rigl Noncash Interest Expense
NoncashInterestExpense
1428000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-107000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
-95000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1726000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1399000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-483000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5158000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
527000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7439000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-571000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
16000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
4458000
rigl Increase Decrease Right Of Use Assets
IncreaseDecreaseRightOfUseAssets
4000000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1585000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2030000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-3165000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1828000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
-1171000
rigl Increase Decrease In Accrued Research And Development Liability
IncreaseDecreaseInAccruedResearchAndDevelopmentLiability
1575000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
4194000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
1436000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4840000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4197000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1053000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
188000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
478000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
43724000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42127000
rigl Cost Share Advance From Collaboration Partner
CostShareAdvanceFromCollaborationPartner
57900000
rigl Payment Of Cost Share To Collaboration Partner
PaymentOfCostShareToCollaborationPartner
8346000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1539000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3416000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
14300000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
9942000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3135000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61316000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
7526000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
8311000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170192000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171961000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169997000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18890000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30373000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27201000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
84823000
us-gaap Interest Paid Net
InterestPaidNet
951000
us-gaap Interest Paid Net
InterestPaidNet
723000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:9pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:9pt;text-indent:36pt;margin:9pt 0pt 0pt 0pt;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from these estimates.</p>
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
89200000
CY2021Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
6321000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13492000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13821000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40937000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25679000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172147000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
170192000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171961000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
169997000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
172147000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
172147000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
170192000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171961000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175912000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34272000
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30873000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
34272000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9473000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29819000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26266000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
46554000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
107284000
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7915000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
13004000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
10688000
CY2022Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
10231000
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
6065000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
7782000
rigl Sales Discounts And Allowances
SalesDiscountsAndAllowances
8700000
CY2022Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
67461000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
610000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
626000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
5000000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
11940095
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
125000
rigl Collaborative Arrangement Upfront Fee Received
CollaborativeArrangementUpfrontFeeReceived
125000000.0
CY2022Q2 us-gaap Accretion Expense
AccretionExpense
0
CY2021Q2 us-gaap Accretion Expense
AccretionExpense
1000000.0
us-gaap Accretion Expense
AccretionExpense
700000
us-gaap Accretion Expense
AccretionExpense
1100000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2391000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2306000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5598000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4945000
CY2022Q1 rigl Extended Exercise Period Number Of Members Of Board Of Directors
ExtendedExercisePeriodNumberOfMembersOfBoardOfDirectors
2
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
800000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
106077000
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
89166000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
124967000
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
67899000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
111978000
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
4555000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
5142000
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
572000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
162000
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1091000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1312000
CY2022Q2 us-gaap Inventory Net
InventoryNet
6218000
CY2021Q4 us-gaap Inventory Net
InventoryNet
6616000
CY2022Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
700000
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
89166000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
124967000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27201000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18890000
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
61965000
CY2021Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
111876000
rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P114D
CY2021 rigl Cash Equivalents And Available For Sale Securities Weighted Average Maturity Period
CashEquivalentsAndAvailableForSaleSecuritiesWeightedAverageMaturityPeriod
P196D
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
34
us-gaap Operating Lease Cost
OperatingLeaseCost
2680000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
163000
us-gaap Variable Lease Cost
VariableLeaseCost
391000
us-gaap Variable Lease Cost
VariableLeaseCost
392000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
67461000
CY2022Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
438000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
100000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7500000
CY2022Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
22500000
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
30000000
CY2022Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M29D
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1340000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1340000
us-gaap Operating Lease Cost
OperatingLeaseCost
2680000
CY2022Q2 us-gaap Lease Cost
LeaseCost
1465000
CY2021Q2 us-gaap Lease Cost
LeaseCost
1503000
us-gaap Lease Cost
LeaseCost
3071000
us-gaap Lease Cost
LeaseCost
3072000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2630000
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2529000
us-gaap Operating Lease Payments
OperatingLeasePayments
5226000
us-gaap Operating Lease Payments
OperatingLeasePayments
5025000
CY2022Q2 rigl Fixed Sublease Expense
FixedSubleaseExpense
1095000
CY2021Q2 rigl Fixed Sublease Expense
FixedSubleaseExpense
1095000
rigl Fixed Sublease Expense
FixedSubleaseExpense
2190000
rigl Fixed Sublease Expense
FixedSubleaseExpense
2190000
CY2022Q2 rigl Variable Sublease Expense
VariableSubleaseExpense
206000
CY2021Q2 rigl Variable Sublease Expense
VariableSubleaseExpense
203000
rigl Variable Sublease Expense
VariableSubleaseExpense
450000
rigl Variable Sublease Expense
VariableSubleaseExpense
444000
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
1301000
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
1298000
us-gaap Sublease Income
SubleaseIncome
2640000
us-gaap Sublease Income
SubleaseIncome
2634000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5260000
CY2022Q2 rigl Sublease Payments To Be Received Remainder Of Fiscal Year
SubleasePaymentsToBeReceivedRemainderOfFiscalYear
2365000
CY2022Q2 rigl Lessee Operating Lease Liability Net Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityNetPaymentsRemainderOfFiscalYear
2895000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
877000
CY2022Q2 rigl Sublease Payments To Be Received Next Twelve Months
SubleasePaymentsToBeReceivedNextTwelveMonths
394000
CY2022Q2 rigl Lessee Operating Lease Liability Net Payments Next Twelve Months
LesseeOperatingLeaseLiabilityNetPaymentsNextTwelveMonths
483000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6137000
CY2022Q2 rigl Sublease Payments To Be Received
SubleasePaymentsToBeReceived
2759000
CY2022Q2 rigl Lessee Operating Lease Liability Net Payments
LesseeOperatingLeaseLiabilityNetPayments
3378000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1000000.0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000

Files In Submission

Name View Source Status
0001558370-22-011638-index-headers.html Edgar Link pending
0001558370-22-011638-index.html Edgar Link pending
0001558370-22-011638.txt Edgar Link pending
0001558370-22-011638-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rigl-20220630.xsd Edgar Link pending
rigl-20220630x10q.htm Edgar Link pending
rigl-20220630x10q004.jpg Edgar Link pending
rigl-20220630x10q_htm.xml Edgar Link completed
rigl-20220630xex10d1.htm Edgar Link pending
rigl-20220630xex31d1.htm Edgar Link pending
rigl-20220630xex31d2.htm Edgar Link pending
rigl-20220630xex32d1.htm Edgar Link pending
rigl-20220630_cal.xml Edgar Link unprocessable
rigl-20220630_def.xml Edgar Link unprocessable
rigl-20220630_lab.xml Edgar Link unprocessable
rigl-20220630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending